PHARMA FLEXFUND Trademark

Trademark Overview

On Wednesday, May 31, 2023, a trademark application was filed for PHARMA FLEXFUND with the United States Patent and Trademark Office. The USPTO has given the PHARMA FLEXFUND trademark a serial number of 98020889. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 30, 2024. This trademark is owned by AscellaHealth LLC. The PHARMA FLEXFUND trademark is filed in the Advertising, Business and Retail Services category with the following description:

Consulting services for manufacturers and payers, namely, providing funding support and customized payment terms for specialty medications
pharma flexfund

General Information

Serial Number98020889
Word MarkPHARMA FLEXFUND
Filing DateWednesday, May 31, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkPHARMACY FLEX FUND
Goods and ServicesConsulting services for manufacturers and payers, namely, providing funding support and customized payment terms for specialty medications

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSunday, July 2, 2023
Primary Code035
First Use Anywhere DateSaturday, April 1, 2023
First Use In Commerce DateSaturday, April 1, 2023

Trademark Owner History

Party NameAscellaHealth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBerwyn, PA 19312

Trademark Events

Event DateEvent Description
Thursday, February 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 21, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 3, 2023NEW APPLICATION ENTERED
Sunday, July 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 30, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 10, 2024NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 21, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 10, 2024ASSIGNED TO EXAMINER
Wednesday, January 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 22, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

flexfund pharma payment customized terms specialty medications support funding manufacturers services payers